Travelers Companies Valuation
Is TRV * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TRV * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TRV * (MX$4975) is trading below our estimate of fair value (MX$6755.3)
Significantly Below Fair Value: TRV * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TRV *?
Other financial metrics that can be useful for relative valuation.
| What is TRV *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$55.76b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 9.4x |
| PEG Ratio | 4.8x |
Price to Earnings Ratio vs Peers
How does TRV *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.1x | ||
Q * Quálitas Controladora. de | 11x | 13.1% | Mex$53.9b |
ALL Allstate | 11.7x | 3.7% | US$48.8b |
8766 Tokio Marine Holdings | 14.2x | 7.1% | JP¥10.6t |
8725 MS&AD Insurance Group Holdings | 11.4x | 8.1% | JP¥5.1t |
TRV * Travelers Companies | 12.2x | 2.6% | Mex$55.8b |
Price-To-Earnings vs Peers: TRV * is expensive based on its Price-To-Earnings Ratio (12.2x) compared to the peer average (11.9x).
Price to Earnings Ratio vs Industry
How does TRV *'s PE Ratio compare vs other companies in the South American Insurance Industry?
Price-To-Earnings vs Industry: TRV * is expensive based on its Price-To-Earnings Ratio (12.2x) compared to the Global Insurance industry average (10.8x).
Price to Earnings Ratio vs Fair Ratio
What is TRV *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 12.2x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate TRV *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$4,975.00 | Mex$5,276.16 +6.1% | 8.9% | Mex$6,226.82 | Mex$4,298.51 | n/a | 21 |
| Oct ’25 | n/a | Mex$4,357.94 0% | 8.6% | Mex$5,472.90 | Mex$3,750.66 | n/a | 22 |
| Sep ’25 | Mex$4,468.23 | Mex$4,202.61 -5.9% | 6.8% | Mex$4,674.35 | Mex$3,664.69 | n/a | 21 |
| Aug ’25 | n/a | Mex$4,198.63 0% | 6.9% | Mex$4,687.80 | Mex$3,675.24 | n/a | 21 |
| Jul ’25 | n/a | Mex$4,157.38 0% | 6.8% | Mex$4,610.47 | Mex$3,659.10 | n/a | 22 |
| Jun ’25 | n/a | Mex$3,812.48 0% | 6.3% | Mex$4,206.11 | Mex$3,371.56 | n/a | 22 |
| May ’25 | Mex$3,649.74 | Mex$3,867.88 +6.0% | 6.4% | Mex$4,274.88 | Mex$3,426.69 | n/a | 22 |
| Apr ’25 | n/a | Mex$3,631.74 0% | 9.6% | Mex$4,338.92 | Mex$2,919.21 | n/a | 23 |
| Mar ’25 | Mex$3,772.51 | Mex$3,694.96 -2.1% | 9.5% | Mex$4,441.85 | Mex$2,988.47 | n/a | 23 |
| Feb ’25 | n/a | Mex$3,716.78 0% | 9.0% | Mex$4,250.55 | Mex$3,021.85 | n/a | 23 |
| Jan ’25 | n/a | Mex$3,269.92 0% | 8.4% | Mex$3,889.83 | Mex$2,824.35 | n/a | 22 |
| Dec ’24 | n/a | Mex$3,425.95 0% | 8.4% | Mex$4,110.86 | Mex$2,984.84 | n/a | 20 |
| Nov ’24 | Mex$2,900.24 | Mex$3,481.69 +20.0% | 8.4% | Mex$4,177.74 | Mex$3,033.40 | Mex$4,975.00 | 20 |
| Oct ’24 | n/a | Mex$3,288.82 0% | 8.1% | Mex$3,921.45 | Mex$2,864.37 | n/a | 19 |
| Sep ’24 | n/a | Mex$3,288.82 0% | 8.1% | Mex$3,921.45 | Mex$2,864.37 | Mex$4,468.23 | 19 |
| Aug ’24 | n/a | Mex$3,246.17 0% | 8.1% | Mex$3,870.60 | Mex$2,827.22 | n/a | 19 |
| Jul ’24 | n/a | Mex$3,353.52 0% | 7.3% | Mex$3,937.49 | Mex$2,944.55 | n/a | 18 |
| Jun ’24 | n/a | Mex$3,476.29 0% | 7.4% | Mex$4,068.33 | Mex$3,042.40 | n/a | 17 |
| May ’24 | n/a | Mex$3,549.12 0% | 7.6% | Mex$4,162.43 | Mex$2,986.09 | Mex$3,649.74 | 18 |
| Apr ’24 | n/a | Mex$3,563.43 0% | 7.0% | Mex$4,145.15 | Mex$3,153.92 | n/a | 18 |
| Mar ’24 | n/a | Mex$3,694.20 0% | 6.9% | Mex$4,282.83 | Mex$3,258.68 | Mex$3,772.51 | 18 |
| Feb ’24 | Mex$3,648.00 | Mex$3,694.20 +1.3% | 6.9% | Mex$4,282.83 | Mex$3,258.68 | n/a | 18 |
| Jan ’24 | n/a | Mex$3,605.23 0% | 6.6% | Mex$4,318.89 | Mex$3,298.06 | n/a | 17 |
| Dec ’23 | n/a | Mex$3,524.65 0% | 6.4% | Mex$4,214.25 | Mex$3,218.16 | n/a | 18 |
| Nov ’23 | n/a | Mex$3,619.43 0% | 6.3% | Mex$4,359.17 | Mex$3,328.82 | Mex$2,900.24 | 18 |
Analyst Forecast: Target price is less than 20% higher than the current share price.